JNC-1043 / J&C Sciences - LARVOL DELTA

Clinical candidate JNC-1043, importin ß inhibitor (first in class), to target incurable cancers, TNBC, and colon cancer. (ASCO 2026) - "JNC-1043 is an importin ß inhibitor and promising clinical candidate for cancer therapy especially TNBC. This poster presents results of JNC-1043 studies that are MOA, in vitro and in vivo efficacy, PK and Tox. studies, and CMC."

Clinical • Colon Cancer • Colorectal Cancer • Oncology • Solid Tumor • Triple Negative Breast Cancer